Iberdomide Versus Observation Off Therapy After Idecabtagene Vicleucel CAR-T for Multiple Myeloma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Sascha A Tuchman
Alliance for Clinical Trials in Oncology
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
74 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Uci Health - Chao Family Comprehensive Cancer Center and Ambulatory Care
Irvine, California, United States
- Cedars-Sinai Medical Center
Los Angeles, California, United States
- Uc Irvine Health/chao Family Comprehensive Cancer Center
Orange, California, United States
- University of California Davis Comprehensive Cancer Center
Sacramento, California, United States
- Augusta University Medical Center
Augusta, Georgia, United States
- University of Illinois
Chicago, Illinois, United States
- Ui Health Care Mission Cancer and Blood - Ankeny Clinic
Ankeny, Iowa, United States
- Ui Health Care Mission Cancer and Blood - West Des Moines Clinic
Clive, Iowa, United States
- Iowa Methodist Medical Center
Des Moines, Iowa, United States
- Mercy Medical Center - Des Moines
Des Moines, Iowa, United States
- Ui Health Care Mission Cancer and Blood - Des Moines Clinic
Des Moines, Iowa, United States
- Ui Health Care Mission Cancer and Blood - Laurel Clinic
Des Moines, Iowa, United States
- Ui Health Care Mission Cancer and Blood - Waukee Clinic
Waukee, Iowa, United States
- Baptist Memorial Hospital and Cancer Center-Desoto
Southhaven, Mississippi, United States
- Siteman Cancer Center at Saint Peters Hospital
City of Saint Peters, Missouri, United States
- Siteman Cancer Center at West County Hospital
Creve Coeur, Missouri, United States
- Siteman Cancer Center at Christian Hospital
St Louis, Missouri, United States
- Siteman Cancer Center-South County
St Louis, Missouri, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- Nebraska Medicine-Bellevue
Bellevue, Nebraska, United States
- Nebraska Medicine-Village Pointe
Omaha, Nebraska, United States
- University of Nebraska Medical Center
Omaha, Nebraska, United States
- Memorial Sloan Kettering Monmouth
Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen
Montvale, New Jersey, United States
- Memorial Sloan Kettering Commack
Commack, New York, United States
- Memorial Sloan Kettering Westchester
Harrison, New York, United States
- Memorial Sloan Kettering Cancer Center
New York, New York, United States
- Unc Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina, United States
- Atrium Health Pineville/lci-Pineville
Charlotte, North Carolina, United States
- Atrium Health University City/lci-University
Charlotte, North Carolina, United States
- Carolinas Medical Center/levine Cancer Institute
Charlotte, North Carolina, United States
- Atrium Health Cabarrus/lci-Concord
Concord, North Carolina, United States
- Levine Cancer Institute - Huntersville
Huntersville, North Carolina, United States
- Atrium Health Union/lci-Union
Monroe, North Carolina, United States
- Wake Forest University Health Sciences
Winston-Salem, North Carolina, United States
- Sanford Broadway Medical Center
Fargo, North Dakota, United States
- Sanford Roger Maris Cancer Center
Fargo, North Dakota, United States
- University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, United States
- Providence Portland Medical Center
Portland, Oregon, United States
- Providence Saint Vincent Medical Center
Portland, Oregon, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 27 Aug 2024
- Primary completion
- 31 Oct 2027
- Completion
- 31 Oct 2027
- Last update posted
- 11 Jun 2026
- Registered enrollment
- 78
- Registry id
- NCT06179888
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.